LGMK LogicMark, Inc. OTC · United States

LogicMark (LGMK) news LGMK merger news

Mergers · Oct 13, 2026

LogicMark completes merger, holders receive $1.31 a share in cash

The merger with Langham Merger Sub took effect on October 13, 2026, and LogicMark is now a wholly owned subsidiary of Langham Project LLC.

Latest LogicMark news

Aug 3, 2026Mergers
LogicMark agrees to $1.31 per share cash merger with Langham Project
The agreement dated July 31, 2026 would convert LogicMark into a wholly owned subsidiary of Langham Project, LLC, subject to a shareholder vote and other conditions.
May 13, 2026Listings
LogicMark revenue rises 24% in first quarter 2026
Revenue reached $3.2 million and gross margin 69.6%, while the operating loss narrowed to $1.5 million and cash and investments totaled $7.5 million.

LogicMark annual financials

Line	FY2025	FY2024
Revenue	$11.4 million	$9.9 million
Research and development	$617,369	$558,621
Net income (loss)	-$7.5 million	-$9.0 million
Cash from operations	-$5.1 million	-$4.3 million
Cash and equivalents	$3.6 million	$3.8 million
Short-term investments	$5.9 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $3.5 million, plus short-term investments of $3.1 million, $6.6 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about LogicMark

Is LogicMark involved in a merger or acquisition?

Our latest story on this, dated Oct 13, 2026: "LogicMark completes merger, holders receive $1.31 a share in cash". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of LogicMark?

LogicMark, Inc. trades under the ticker LGMK on OTC.

Where is LogicMark listed?

LogicMark, Inc. is listed on OTC.

Which country or territory is LogicMark listed under?

Our directory records LogicMark, Inc. under United States.

Does aibio.space cover LogicMark?

aibio.space lists LogicMark, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was LogicMark's revenue last year?

$11.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is LogicMark profitable?

LogicMark, Inc. reported a net loss of $7.5 million for the fiscal year ended Dec 31, 2025, and used $5.1 million of cash in operations, per its annual report to the SEC.

How much does LogicMark spend on research and development?

$617,369 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does LogicMark have?

$6.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.

What is the latest LogicMark (LGMK) stock news?

Our latest story on LogicMark, dated Oct 13, 2026: "LogicMark completes merger, holders receive $1.31 a share in cash". The merger with Langham Merger Sub took effect on October 13, 2026, and LogicMark is now a wholly owned subsidiary of Langham Project LLC. Source.

Is LogicMark at risk of delisting?

Our latest listing story, dated May 13, 2026: "LogicMark revenue rises 24% in first quarter 2026". Revenue reached $3.2 million and gross margin 69.6%, while the operating loss narrowed to $1.5 million and cash and investments totaled $7.5 million. Source.

How can I follow LogicMark (LGMK) news?

Press Follow on this page to add LogicMark to your Following list, or subscribe to the aibio.space newsletter. We have published 3 stories naming LogicMark so far, in Listings, Mergers.

Investor discussion: LogicMark

Members talk about LogicMark (LGMK). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at LogicMark, newest first. Each line links the filing it comes from.

Oct 15, 2026Listings
Filed to end its SEC reporting. SEC Form 15-12G. Source
Oct 13, 2026Mergers
Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,3.03,5.01,5.02,5.03,9.01). Source
Aug 17, 2026Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
Aug 3, 2026Mergers
Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,9.01). Source
May 15, 2026Listings
Reported a reverse stock split. SEC Form 8-K (Items 2.02,7.01,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:LGMK on TradingView.

Listing details

LogicMark, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker LGMK, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company: LogicMark, Inc.
Ticker: LGMK
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction